Clinical Trial Update: A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for GS3-007a in adults with growth hormone deficiency; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• GS3-007a

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Adult Growth Hormone Deficiency (AGHD) | Phase 2 | Status: NOT_YET_RECRUITING